CJC-1295 Without DAC (5 mg)

What is CJC-1295 – No DAC (5mg)?

CJC-1295 – No DAC (5mg) is a synthetic growth hormone–releasing hormone (GHRH) analog used in laboratory research to study endocrine signaling and growth hormone–axis biology. It belongs to the endocrine/metabolic peptide category, specifically the GHRH-analog subcategory.

“No DAC” means it lacks the Drug Affinity Complex (DAC) found in long-acting CJC-1295 designs, making it suitable for experiments that focus on capturing cleaner time-course relationships between exposure and measured markers. This version of CJC-1295 allows researchers to examine receptor-linked signaling and downstream biomarker patterns over time, making it ideal for controlled models that require short-duration peptide signaling.

Product Specifications

• CAS Number: 863288-34-0
• Peptide Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg
• Chemical Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• Molecular Weight: 3367.9 g/mol
• Purity: ≥99% (or >99%)
• Packaging Format: 5 mg
• Storage Conditions: Store at -20°C, avoid light exposure
• For Laboratory Research Use Only

Key Characteristics of CJC-1295 – No DAC (5mg)

• Synthetic peptide designed for controlled research applications to study growth hormone–related signaling.
• No DAC version: A truncated GHRH-related analog lacking the DAC extension used in long-acting constructs, enabling short-duration signaling studies.
• High purity (≥99%): Intended to reduce confounding from impurities in analytical or cell-based workflows.
• Convenient 5 mg format: Often selected for pilot assays, replicate runs, and controlled comparative studies (study-dependent).
• Cold storage + light protection: Basic storage expectations to help preserve integrity before use in assays.
• Compatible with standard peptide handling and cold-chain storage protocols.

How CJC-1295 – No DAC (5mg) Supports Research

CJC-1295 – No DAC is used in laboratory studies as a GHRH-analog research reagent in endocrine pathway studies. In controlled models, it helps researchers investigate how GHRH receptor–linked signaling interacts with cellular responses and how to track downstream biomarkers or transcriptional readouts, depending on the assay design.